96 related articles for article (PubMed ID: 26854490)
1. Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival.
Roh MR; Gupta S; Park KH; Chung KY; Lauss M; Flaherty KT; Jönsson G; Rha SY; Tsao H
J Invest Dermatol; 2016 May; 136(5):1002-1011. PubMed ID: 26854490
[TBL] [Abstract][Full Text] [Related]
2. Revisiting the Clinical and Biologic Relevance of Partial PTEN Loss in Melanoma.
Giles KM; Rosenbaum BE; Berger M; Izsak A; Li Y; Illa Bochaca I; Vega-Saenz de Miera E; Wang J; Darvishian F; Zhong H; Osman I
J Invest Dermatol; 2019 Feb; 139(2):430-438. PubMed ID: 30148988
[TBL] [Abstract][Full Text] [Related]
3. Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma.
Mitra S; Lauss M; Cabrita R; Choi J; Zhang T; Isaksson K; Olsson H; Ingvar C; Carneiro A; Staaf J; Ringnér M; Nielsen K; Brown KM; Jönsson G
Mol Oncol; 2020 May; 14(5):933-950. PubMed ID: 32147909
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation characteristics of primary melanomas with distinct biological behaviour.
Ecsedi S; Hernandez-Vargas H; Lima SC; Vizkeleti L; Toth R; Lazar V; Koroknai V; Kiss T; Emri G; Herceg Z; Adany R; Balazs M
PLoS One; 2014; 9(5):e96612. PubMed ID: 24832207
[TBL] [Abstract][Full Text] [Related]
5. Infrequent hypermethylation of the PTEN gene in Korean non-small-cell lung cancers.
Kim DS; Lee SM; Yoon GS; Choi JE; Park JY
Cancer Sci; 2010 Feb; 101(2):568-72. PubMed ID: 20175786
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations of PTEN in human melanoma.
Aguissa-Touré AH; Li G
Cell Mol Life Sci; 2012 May; 69(9):1475-91. PubMed ID: 22076652
[TBL] [Abstract][Full Text] [Related]
7. Systemic Analysis of the Prognosis-Related RNA Alternative Splicing Signals in Melanoma.
Xue D; Cheng P; Jiang J; Ren Y; Wu D; Chen W
Med Sci Monit; 2020 Mar; 26():e921133. PubMed ID: 32199022
[TBL] [Abstract][Full Text] [Related]
8.
Geybels MS; Fang M; Wright JL; Qu X; Bibikova M; Klotzle B; Fan JB; Feng Z; Ostrander EA; Nelson PS; Stanford JL
Oncotarget; 2017 Oct; 8(48):84338-84348. PubMed ID: 29137428
[TBL] [Abstract][Full Text] [Related]
9. Phosphatase and Tensin Homolog (PTEN) Expression as a Surrogate Biomarker Correlated With the Depth of Invasion in Cutaneous Malignant Melanoma.
Sun Z; Arnouk H
Cureus; 2023 Sep; 15(9):e45295. PubMed ID: 37846279
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of an m6A RNA methylation regulator-based signature for the prediction of prognosis and immunotherapy in cutaneous melanoma.
Li T; Zhang X; Wang C; Jia Q; Zhong L; Hu J; Li H; Zhang J
Chin Med J (Engl); 2023 Nov; 136(21):2641-2643. PubMed ID: 37036897
[No Abstract] [Full Text] [Related]
11. The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response.
Cabrita R; Mitra S; Sanna A; Ekedahl H; Lövgren K; Olsson H; Ingvar C; Isaksson K; Lauss M; Carneiro A; Jönsson G
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32245160
[TBL] [Abstract][Full Text] [Related]
12. Correction: Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance.
Williams JTW; Bell KJL; Morton RL; Dieng M
Appl Health Econ Health Policy; 2024 Mar; 22(2):271-272. PubMed ID: 38214849
[No Abstract] [Full Text] [Related]
13. TERT promoter mutations in melanoma survival.
Nagore E; Heidenreich B; Rachakonda S; Garcia-Casado Z; Requena C; Soriano V; Frank C; Traves V; Quecedo E; Sanjuan-Gimenez J; Hemminki K; Landi MT; Kumar R
Int J Cancer; 2016 Jul; 139(1):75-84. PubMed ID: 26875008
[TBL] [Abstract][Full Text] [Related]
14. The next generation of metastatic melanoma: uncovering the genetic variants for anti-BRAF therapy response.
Pinto R; De Summa S; Strippoli S; Pilato B; Azzariti A; Guida G; Guida M; Tommasi S
Oncotarget; 2016 May; 7(18):25135-49. PubMed ID: 26863566
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma.
Venza M; Visalli M; Catalano T; Biondo C; Beninati C; Teti D; Venza I
Oncol Rep; 2016 Apr; 35(4):2451-60. PubMed ID: 26883095
[TBL] [Abstract][Full Text] [Related]
16. Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.
Gibbs DC; Orlow I; Bramson JI; Kanetsky PA; Luo L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Sharma A; La Pilla E; From L; Busam KJ; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 26857527
[TBL] [Abstract][Full Text] [Related]
17. Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.
Jacquelot N; Enot DP; Flament C; Vimond N; Blattner C; Pitt JM; Yamazaki T; Roberti MP; Daillère R; Vétizou M; Poirier-Colame V; Semeraro M; Caignard A; Slingluff CL; Sallusto F; Rusakiewicz S; Weide B; Marabelle A; Kohrt H; Dalle S; Cavalcanti A; Kroemer G; Di Giacomo AM; Maio M; Wong P; Yuan J; Wolchok J; Umansky V; Eggermont A; Zitvogel L
J Clin Invest; 2016 Mar; 126(3):921-37. PubMed ID: 26854930
[TBL] [Abstract][Full Text] [Related]
18. BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival.
Hugdahl E; Kalvenes MB; Puntervoll HE; Ladstein RG; Akslen LA
Br J Cancer; 2016 Mar; 114(7):801-8. PubMed ID: 26924424
[TBL] [Abstract][Full Text] [Related]
19. Malignant Transformation of a Dysembryoplastic Neuroepithelial Tumor (DNET) Characterized by Genome-Wide Methylation Analysis.
Heiland DH; Staszewski O; Hirsch M; Masalha W; Franco P; Grauvogel J; Capper D; Schrimpf D; Urbach H; Weyerbrock A
J Neuropathol Exp Neurol; 2016 Apr; 75(4):358-65. PubMed ID: 26921879
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial treatment with anacardic acid followed by TRAIL augments induction of apoptosis in TRAIL resistant cancer cells by the regulation of p53, MAPK and NFκβ pathways.
Harsha Raj M; Yashaswini B; Rössler J; Salimath BP
Apoptosis; 2016 May; 21(5):578-93. PubMed ID: 26921178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
